AzTrials
AzTrials

Childhood Obesity PreventionPEABaByNCT07467694

Postnatal Exercise to Activate Baby's Brown Fat

A study testing Active group in people with Childhood Obesity Prevention and Childhood Obesity, run by Joslin Diabetes Center at 2 sites in United States.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The purpose of this study is to learn how exercise and physical activity during pregnancy and after pregnancy may affect the composition of breastmilk. Certain changes in breast milk after exercise may have an impact on how infants use energy. Read more about this study

Who is it for?
Ages 18 to 45 years, women onlyHealthy volunteers can take part
What is being tested?
Active group
Could I receive a placebo?
No, everyone receives an active treatment
How many people
200 participants
Where
2 sitesUnited States
Study dates
1 Dec 2025to 1 Jul 2030
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 45 years
  • Women only
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • 18-45 y of age at the time of enrollment
  • Pre-gravid or first trimester BMI 18.5 -40 kg/m2
  • Uncomplicated singleton pregnancy
  • Intention to exclusively breastfeed for >3 months and, if parity >1, that they successfully breastfed a previous pregnancy
  • Term pregnancy (gestational age 37 to <42 weeks)
  • Infant with birth weight >10th percentile of weight for gestational age

Who cannot join

  • Any obstetric contra-indication to exercise at 1 month
  • Diagnosis of uncontrolled (HbA1c >7%) type 1 or type 2 diabetes, or gestational diabetes managed with insulin
  • Intrauterine growth restriction
  • Pre-eclampsia or other pregnancy complications
  • Alcohol, cannabis or tobacco use
  • Known congenital metabolic, endocrine disease, or congenital illness affecting infant feeding/growth
  • Major fetal anomalies
  • Musculoskeletal issues that would make exercise difficult

Trial locations and contacts

2 sites in 1 country. Contact the study team or a site near you to ask about taking part.

Elvira M Isganaitis, MD, MPH contact

617-309-4554

elvira.isganaitis@joslin.harvard.edu

United States2 sites, 2 recruiting
  • Joslin Diabetes Center

    Boston, Massachusetts, 02215

    Elvira Isganaitis, MD, elvira.isganaitis@joslin.harvard.edu

    Recruiting
  • Oklahoma University College of Medicine

    Oklahoma City, Oklahoma, 73104

    Katy Duncan, katy-duncan@ou.edu

    David Fields, PhD

    Recruiting

Other trials in United States

About this study

Official title: Impact of Acute Exercise and Habitual Physical Activity on Human Milk Composition and Childhood Obesity Risk

The purpose of this study is to learn how exercise and physical activity during pregnancy and after pregnancy may affect the composition of breastmilk. Certain changes in breast milk after exercise may have an impact on how infants use energy. Understanding this process may improve public health recommendations for exercise during and after pregnancy. This study can help investigators learn more about how maternal exercise patterns may affect body growth and obesity risk in infants who are breastfed. This research may help identify how different factors can influence healthy weight and early development in infants.

Read the detailed description

Epidemiological studies suggest that breastfeeding protects against risk of obesity, diabetes, asthma, and other childhood diseases. However, the specific compounds within breastmilk that are responsible for its protective effects are not fully understood. Moreover, prior work from this investigative team has shown that human milk composition varies substantially between individuals according to factors such as body mass index (BMI), diabetes status, diet, and physical activity. Gaining a better understanding of how modifiable risk factors may impact human milk composition would have the potential to identify strategies to enhance the health-promoting benefits of human milk.

In this project, the investigators will study the impact of maternal exercise on human milk composition. The central hypothesis is that maternal exercise induces changes in breast milk metabolites and lipids that result in activation of infant brown fat, increased infant energy expenditure, and reduced obesity risk.

The study will include assessments of habitual activity during pregnancy and the postpartum period, supervised bouts acute moderate exercise, as well as analysis of human milk composition, infant growth and body composition, and infant energy expenditure.

Being tested
Active group
Keywords
Lactation, Breastfeeding, Breast milk, Pregnancy, Exercise
Medical subject headings
Pediatric Obesity, Motor Activity, Breast Feeding

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Active groupBehavioural

    For participants randomized to the Active group, there will be weekly phone calls with study staff during which step counts and exercise bouts from the previous week will be reviewed, and exercise goals for the following week will be gradually increased.

Study groups in NCT07467694
Study groupRoleWhat they receive
Enhanced physical activityExperimentalParticipants in this group will be encouraged to engage in daily physical activity
Receives: Behavioral: Active group
Control groupNo interventionUsual care

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Altered breast milk lipidome

    Milk composition measured through lipidomics

    Measured: 8 weeks

  2. Altered breast milk metabolome

    Human milk composition measured via metabolomics

    Measured: 8 weeks

Secondary outcomes (3)
  1. Infant body composition

    Infant body composition will be measured using air-displacement plethysmography (ADP; i.e., PeaPod) at 1 and 3-mo and by DXA at 6 and 12-mo: percentage fat, total fat mass.

    Measured: 3 months, 6 months, and 12 months

  2. Infant body mass index (BMI)

    Body mass index (BMI) z-score for age and sex, usual range [-4,4]; lower BMI z-score represents lower adiposity

    Measured: 3 months, 6 months, and 12 months

  3. Infant resting metabolic rate

    Infant Resting Metabolic Rate

    Measured: 3 months of age

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted12 Mar 2026
  2. Study start1 Dec 2025
  3. Primary completion1 Jul 2030 (estimated)
  4. Study completion1 Jul 2030 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
200 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07467694
Sponsor's protocol ID
STUDY00000313
Other IDs
R01HD117197
Acronym
PEABaBy
Status last verified
Mar 2026
First submitted
17 Feb 2026
Last updated
12 Mar 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

A study testing Active group in people with Childhood Obesity Prevention and Childhood Obesity, run by Joslin Diabetes Center at 2 sites in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 12 Mar 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Elvira M Isganaitis, MD, MPH (617-309-4554, elvira.isganaitis@joslin.harvard.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Altered breast milk lipidome (time frame: 8 weeks). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 Mar 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in